Shuttle Pharmaceuticals received a notification from Nasdaq on August 28, 2026, indicating non-compliance with listing requirements due to the delayed filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2026. The notice has no immediate effect on the company's stock listing or trading.
Key Details
- Non-Compliance: The company failed to meet the filing deadline required by Nasdaq Listing Rule 5250(c)(1).
- Compliance Plan Deadline: Shuttle has until October 27, 2026, to submit a plan to Nasdaq to regain compliance.
- Potential Extension: If the plan is accepted, Nasdaq may grant an extension of up to 180 days from the 10-Q's original due date, or until February 22, 2027, to regain compliance.
- Next Steps: The company is working to file the Form 10-Q as soon as practicable. Failure to regain compliance in a timely manner could result in the stock being delisted from Nasdaq.